ArticleJournal of clinical medicine2024

Evaluation of a Combinatorial Immunotherapy Regimen That Can Cure Mice Bearing MYCN-Driven High-Risk Neuroblastoma That Resists Current Clinical Therapy.

Lauren Zebertavage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.